Mateu Segui-Diaz

Es Castell, PM, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Type 3 c diabetes: Approach from the first level doctor

Type 3 c diabetes: Approach from the first level doctor

Journal: Semergen

Published: June 22, 2023

Use of dipeptidyl peptidase-4 inhibitors in diabetic patients in special situations

Use of dipeptidyl peptidase-4 inhibitors in diabetic patients in special situations

Journal: Semergen

Published: October 17, 2018

Efficacy of anti-inflammatory non-steroidal drugs in the treatment of knee and hip pain

Efficacy of anti-inflammatory non-steroidal drugs in the treatment of knee and hip pain

Journal: Semergen

Published: June 08, 2016

A 31 year-old patient with polydipsia

A 31 year-old patient with polydipsia

Journal: Semergen

Published: May 13, 2016

Is there a link between marijuana use and the risk of having psychiatric disorders?

Is there a link between marijuana use and the risk of having psychiatric disorders?

Journal: Semergen

Published: May 03, 2016

Does happiness influence mortality?

Does happiness influence mortality?

Journal: Semergen

Published: April 10, 2016

The eternal problem of false positives in mammography screening

The eternal problem of false positives in mammography screening

Journal: Semergen

Published: March 10, 2016

What is the best treatment for urogenital Chlamydia trachomatis infection?

What is the best treatment for urogenital Chlamydia trachomatis infection?

Journal: Semergen

Published: February 07, 2016

There are differences in body weight between diets

There are differences in body weight between diets

Journal: Semergen

Published: January 09, 2016

Effect of financial incentives on LDL-cholesterol levels

Effect of financial incentives on LDL-cholesterol levels

Journal: Semergen

Published: December 07, 2015

Varenicline in nicotine replacement therapy: Does it really increase the risk of cardiovascular and neuropsychiatric events?

Varenicline in nicotine replacement therapy: Does it really increase the risk of cardiovascular and neuropsychiatric events?

Journal: Semergen

Published: November 05, 2015

Empagliflozin reduces cardiovascular mortality in diabetic patients with previous cardiovascular events

Empagliflozin reduces cardiovascular mortality in diabetic patients with previous cardiovascular events

Journal: Semergen

Published: October 05, 2015

Showing 1-12 of 52

Last Updated: 09/26/2026